Purchases and Sales Made in Q3 2024 in Calliditas Therapeutics Ab (CALT)
This table provides information about the institutional ownership of Calliditas Therapeutics Ab (CALT) during Q3 2024. The information is specifically focused on institutions that hold shares of Calliditas Therapeutics AB.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 04, 2024
Q3 2024
|
Crossmark Global Holdings, Inc.
|
BUY
|
- |
16.1KNew |
$612K - $670K
|
16.1K
$645K
|
|
Oct 15, 2024
Q3 2024
|
Advisors Preferred, LLC
Rockville, MD |
BUY
|
- |
2.02KNew |
$76.8K - $84K
|
2.02K
$80.9K
|
|
Nov 08, 2024
Q3 2024
|
Simplex Trading, LLC
|
BUY
|
- |
1.83KNew |
$69.4K - $75.9K
|
1.83K
$73K
|
|
Nov 12, 2024
Q3 2024
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
101+ 50.0% |
$3.84K - $4.2K
|
303
$12.1K
|